Default company panoramic image
Logo

Summit Biosciences Inc.

Our goals are to commercialize nasally delivered drug products for the benefit of patients while creating great value for our stakeholders.

  • Stage $500K in TTM Revenue
  • Industry Other
  • Location Lexington, KY, USA
  • Currency USD
  • Founded December 2008
  • Employees 18
  • Website summitbiosciences.com

Company Summary

Summit Biosciences Inc. is a specialty pharmaceutical company focused on developing, manufacturing and commercializing generic and innovative nasal spray drug products. We provide contract development and manufacturing services to our partners and to our clients for a wide variety of nasally delivered drug products and delivery systems. Our products are designed to provide patients with easy to use, safe and effective drug products at lower cost.

Team

  • Default avatar
    Edwin Cohen
    Chairman and CEO
    Unconfirmed

    Mr. Cohen is a 45 year veteran of the pharmaceutical industry. He is founder and former Chairman of Barr Laboratories which was acquired for $7.5B by Teva in 2008.

  • Default avatar
    Greg Plucinski
    COO
    Unconfirmed

    Mr. Plucinski is an operations executive with 23 years of industry experience leading teams to develop and manufacture a diverse array of drug products including nasal sprays, injectables and a dry powder inhaler.

  • Default avatar
    Sonia Egbert
    CAO
    Unconfirmed

    Mrs. Egbert is a CPA with over 23 years of experience in the fields of finance and accounting.

Advisors

  • Default avatar
    William G. Strench, FrostBrownTodd
    Lawyer
    Unconfirmed
    Default avatar
    Strothman and Company
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Kentucky Science and Technology Corporation
    Unconfirmed
    Default avatar
    Kentucky Technology Inc.
    Unconfirmed
    Default avatar
    Bluegrass Angels, Yearling Fund, Enterprise Angel Members
    Unconfirmed